Linhua Yang

880 total citations · 1 hit paper
25 papers, 515 citations indexed

About

Linhua Yang is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Linhua Yang has authored 25 papers receiving a total of 515 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 11 papers in Molecular Biology and 8 papers in Oncology. Recurrent topics in Linhua Yang's work include Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Linhua Yang is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers), RNA modifications and cancer (6 papers) and MicroRNA in disease regulation (4 papers). Linhua Yang collaborates with scholars based in China, United States and Australia. Linhua Yang's co-authors include Ming Zhan, Jian Wang, Sunwang Xu, Ruimeng Yang, Yongheng Shi, Shuai Huang, Hui Shen, Hui Wang, Min He and Qiang Liu and has published in prestigious journals such as Nature Communications, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Linhua Yang

24 papers receiving 508 citations

Hit Papers

Molecular mechanisms and therapeutic strategies in overco... 2025 2026 2025 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer
    2025 33 citations Ruifeng Yang, Yang Zhang et al. Molecular Biomedicine profile →

Peers

Linhua Yang
Lizhen Wei China
Xin Luo China
Zhouliang Wu China
Huiliang Yang China
Drew D. Moore United States
Hailong Hu China
Yuepeng Cao China
Miaozun Zhang China
Lizhen Wei China
Linhua Yang
Citations per year, relative to Linhua Yang Linhua Yang (= 1×) peers Lizhen Wei

Countries citing papers authored by Linhua Yang

Since Specialization
Citations

This map shows the geographic impact of Linhua Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linhua Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linhua Yang more than expected).

Fields of papers citing papers by Linhua Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linhua Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linhua Yang. The network helps show where Linhua Yang may publish in the future.

Co-authorship network of co-authors of Linhua Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Linhua Yang. A scholar is included among the top collaborators of Linhua Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linhua Yang. Linhua Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yang, Ruifeng, et al.. (2025). Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer. Molecular Biomedicine. 6(1). 2–2. 33 indexed citations breakdown →
3.
Yang, Ruifeng, Linhua Yang, Manmei Long, et al.. (2023). Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation. Oncogene. 42(18). 1466–1477. 8 indexed citations
4.
Yang, Linhua, Hui Wang, Min He, et al.. (2023). ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer. Cellular Oncology. 46(4). 1085–1095. 5 indexed citations
5.
Tang, Liang, Ming-Hui Zheng, Danlei Chen, et al.. (2023). PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma. BMC Gastroenterology. 23(1). 2–2. 4 indexed citations
6.
He, Min, et al.. (2022). Development and validation of a prognostic nomogram for gallbladder cancer patients after surgery. BMC Gastroenterology. 22(1). 200–200. 12 indexed citations
7.
Yang, Ruimeng, Hui Wang, Miaomiao Guo, et al.. (2021). The RNA methyltransferase NSUN6 suppresses pancreatic cancer development by regulating cell proliferation. EBioMedicine. 63. 103195–103195. 83 indexed citations
8.
Zhan, Ming, et al.. (2021). In vivo Analysis of the Resistance of the Meshes to Escherichia coli Infection. Frontiers in Surgery. 8. 644227–644227. 4 indexed citations
9.
Liu, Huimin, Chunling Guo, Yaofang Zhang, et al.. (2021). Leonurine-Repressed miR-18a-5p/SOCS5/JAK2/STAT3 Axis Activity Disrupts CML malignancy. Frontiers in Pharmacology. 12. 657724–657724. 19 indexed citations
10.
Lin, Ruirong, Ming Zhan, Linhua Yang, et al.. (2020). Deoxycholic acid modulates the progression of gallbladder cancer through N6-methyladenosine-dependent microRNA maturation. Oncogene. 39(26). 4983–5000. 76 indexed citations
11.
Cao, Rong, Keqi Wang, Manmei Long, et al.. (2020). miR-3613-5p enhances the metastasis of pancreatic cancer by targeting CDK6. Cell Cycle. 19(22). 3086–3095. 15 indexed citations
12.
Wang, Meifang, et al.. (2019). Tobacco smoke exposure and the risk of childhood acute lymphoblastic leukemia and acute myeloid leukemia. Medicine. 98(28). e16454–e16454. 25 indexed citations
13.
Xu, Sunwang, Ming Zhan, Min He, et al.. (2019). Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer. Nature Communications. 10(1). 5492–5492. 70 indexed citations
14.
Zhan, Ming, Hui Wang, Sunwang Xu, et al.. (2019). Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer. EBioMedicine. 48. 143–160. 17 indexed citations
15.
Yang, Ruimeng, Ming Zhan, Sunwang Xu, et al.. (2017). miR-3656 expression enhances the chemosensitivity of pancreatic cancer to gemcitabine through modulation of the RHOF/EMT axis. Cell Death and Disease. 8(10). e3129–e3129. 39 indexed citations
16.
Chen, Tao, Yunhe Zhang, Haolu Wang, et al.. (2015). Emergency inguinal hernia repair under local anesthesia: a 5-year experience in a teaching hospital. BMC Anesthesiology. 16(1). 17–17. 10 indexed citations
17.
Zhan, Ming, Hui Wang, Tao Chen, et al.. (2015). NOX1 mediates chemoresistance via HIF1α/MDR1 pathway in gallbladder cancer. Biochemical and Biophysical Research Communications. 468(1-2). 79–85. 26 indexed citations
18.
Yang, Linhua, Haowei Wang, Xiaowen Liang, et al.. (2014). Bacteria in hernia sac: an important risk fact for surgical site infection after incarcerated hernia repair. Hernia. 19(2). 279–283. 28 indexed citations
19.
Yang, Linhua, et al.. (2010). The effect of isoflurane or propofol anaesthesia on liver injury after partial hepatectomy in cirrhotic patients. Anaesthesia. 65(11). 1094–1100. 13 indexed citations
20.
Yang, Yirong, et al.. (2009). [Mechanism of C-reactive protein on proliferation of multiple myeloma U266 cells].. PubMed. 17(5). 1242–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lizhen Wei Breakdown of academic impact, for papers by Xin Luo Breakdown of academic impact, for papers by Zhouliang Wu Breakdown of academic impact, for papers by Huiliang Yang Breakdown of academic impact, for papers by Drew D. Moore Breakdown of academic impact, for papers by Hailong Hu Breakdown of academic impact, for papers by Yuepeng Cao Breakdown of academic impact, for papers by Miaozun Zhang
Rankless by CCL
2026